Biofrontera BFRI
NASDAQ BFRI
$1.04 -0.04 (-3.70%)
At close: Oct 1, 2026 · 4:00 PM EDT

Biofrontera (BFRI) Non Operating Interest Expenses (2023 - 2025)

Updated

Biofrontera (BFRI) reported Non Operating Interest Expenses of $120,000 for Q1 2025, down 91.6% from $1.42 million a year earlier and down 80.7% from the prior quarter.

Analysis

Biofrontera (BFRI) Non Operating Interest Expenses (2023 - 2025) Analysis & Trends

Over the twelve months ended Mar 31, 2025, Biofrontera's Non Operating Interest Expenses came in at $2.17 million; for FY2024, it was $2.11 million, up 770.2% from FY2023.

  • By year, Non Operating Interest Expenses came in at $242,000 in FY2023.
  • Five-year quarterly Non Operating Interest Expenses spans a low of $9,000 in Q3 2024 and a high of $1.42 million in Q1 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Biofrontera 15.34 Mn -6.45 Mn 9.59 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 120,000.00
Dec 31, 2024 621,000.00
Sep 30, 2024 9,000.00
Mar 31, 2024 1.42 Mn
Dec 31, 2023 143,000.00
Sep 30, 2023 65,000.00
API Access

Biofrontera Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=BFRI&period=max&api_key=YOUR_API_KEY